Acera Surgical Inc.
Founded in 2013 and based in St. Louis, MO, Acera delivers new technology and is revolutionizing patient care. In 2009, while an MD / Ph.D. student at Washington University, Matthew MacEwan worked with bioengineering graduate students investigating methods to create novel polymer biomaterials. Matthew was intrigued by the structure and its unique properties and focused his research on the potential use of these fibers in the medical field. The turning point came in the summer of 2011 when Matthew was first introduced to Agnès Rey-Giraud, a retired Senior Executive and sought after industry leader. Together, they built the business case for a potential product and pursued the path to clinical validation, FDA clearance, and commercialization.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2013
About Us
Following successful product tests, the business progressed to the development of Cerafix, a fully synthetic dural repair matrix whose scale and architecture resembles native tissue. In 2016, the device received clearance to be marketed and distributed in the U.S. It was soon followed by Restrata, offering a fully resorbable fully synthetic hybrid-scale fiber matrix for soft-tissue repair. All Acera products are based on the groundbreaking hybrid-scale fiber matrix technology in which Matthew and Agnès saw such potential and worked to bring to market.
Innovative technological solutions backed by proven results and a foundational passion for improving lives drives Acera to continue advancing the field of soft-tissue repair. The proven healing power of synthetic electrospun hybrid-scale fiber technology pioneered by Acera is now available in surgical matrices, providing relief to patients who suffer from surgical wounds, trauma, burns, and chronic wounds, among other indications.
Our Mission
Acera’s mission is to set a new standard of excellence in healthcare. We take seriously the trust placed in us by patients and clinicians alike. Our team of pioneers, change agents, innovators, and scientists are bound together by an unrelenting drive to create solutions that make patients’ lives better through the development of revolutionary products that enable healing and enhance quality of life.
A Message to our Customers and Stakeholders:
Acera Surgical takes the health and well-being of our employees, as well as the patients and customers we serve, very seriously. During this COVID-19 crisis, we have taken the necessary safety measures established by the CDC to help protect our employees and their families. At the same time, we remain committed to meeting the needs of our customers and patients.
Our lead product, Restrata, is indicated for use in the management of wounds, including surgical and trauma wounds, along with pressure, diabetic, venous, and chronic vascular ulcers1. Other solutions for soft-tissue repair present tradeoffs, either for patients or providers. Autografts require a second procedure to harvest skin from a patient, leading to increased OR time and patient discomfort; many allografts require tissue tracking and special storage requirements; while most xenografts include biologic components derived from animal tissue that could present a risk of disease transmission to the patient2.
How we can help:
- We manufacture our non-biologic, fully synthetic products in the U.S.A.
- Unlike human or animal based tissue products, Restrata eliminates the risk of disease transmission associated with harvested tissues2
- Restrata is terminally sterilized with a two-year shelf-life, and does not require any special tissue tracking or storage requirements
- We have a strong supply-chain and sufficient inventory on hand to help providers and patients
Mission & Values
Experience the Acera Difference
Acera’s mission is to set a new standard of excellence in healthcare. We take seriously the trust placed in us by patients and clinicians alike. Our team of pioneers, change agents, innovators, and scientists are bound together by an unrelenting drive to create solutions that make patients’ lives better through the development of revolutionary products that enable healing and enhance quality of life.
Acera’s core values of compassion, integrity, excellence, collaboration, and boldness have helped build a culture in which the patient takes primary importance. This patient focus guides every aspect of the business, from product development to sales and operations. The revolutionary healing products Acera designs and the uncompromising, patient-focused, business strategy followed challenge the status quo of both treatment methods and industry practices, setting a new standard for excellence.
Acera is defined by our patient focus and driven by a sense of empathy for those we have the privilege to serve. We are accountable to the clinicians and patients who place their trust in our products. This sense of responsibility is evidenced by the integrity with which we approach our work every day. Our determination to revolutionize healing and improve lives drives our collaboration to produce new products with a reputation for excellence in the market. Acera was born from innovation, and the bold spirit of invention continues to drive us forward.